Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast cancer patients in the D.C. area.
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.
WASHINGTON (June 15, 2017) — The George Washington University (GW) Cancer Center is pleased to announce the opening of the Supportive Oncodermatology Clinic. This clinic is the only one of...
WASHINGTON (June 14, 2017) — Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. Research published in Nature Communications...
Congratulations to Jennifer Bires, LICSW, OSW-C, program coordinator of patient support services at the George Washington University (GW) Cancer Center. Bires will be named 2017 Oncology Social Worker of the Year at the Association of Oncology Social Work (AOSW) Annual Conference to be held May 31-June 2 in Denver.
Ahead of World Cancer Day, prominent Young Leaders from the Union for International Cancer Control (UICC) presented their vision for a new generation of cancer control access and equity in a commentary published in the latest Lancet Oncology journal.
Published in the Journal of the European Academy of Dermatology & Venereology, the study had nearly 20,000 participants from 23 countries
Years of hard work and dedication toward enhancing George Washington University's cancer research and care culminated at the grand opening of the GW Cancer Center’s new space in the Science and Engineering Hall.
The George Washington University (GW) formally launched the GW Cancer Center with a ribbon-cutting and grand opening celebration the evening of Wednesday, Dec. 7. The celebration took place on the eighth floor of the Science and Engineering Hall, where the new GW Cancer Center offices and lab spaces are located. The event signals a historic commitment from GW in the fight against cancer and the commitment to finding a cure.
The George Washington University (GW) is pleased to formally launch the GW Cancer Center with a ribbon cutting ceremony and grand opening celebration. The event will be held at the GW Cancer Center’s new lab and office space located on the eighth floor of the GW Science and Engineering Hall on Wed., Dec. 7 at 5:30 p.m.
The George Washington University (GW) Cancer Center is pleased to announce that Eduardo M. Sotomayor, M.D., inaugural director of the GW Cancer Center, was elected to serve on the Board of Directors of the Association of American Cancer Institutes (AACI)
Within their respective labs, Eduardo Sotomayor, M.D., director of the GW Cancer Center and professor of medicine at the GW School of Medicine and Health Sciences (SMHS), and Edward Seto, Ph.D., professor of biochemistry and molecular medicine at SMHS, are coming closer to the pinnacle of...
Cancer is like publishing a book, Eduardo Sotomayor, M.D., professor of medicine at George Washington University (GW) School of Medicine and Health Sciences (SMHS), and director of the GW Cancer Center, tells his patients. “Currently most of the investment in cancer research is in the last...
Congratulations to Mandi Pratt-Chapman, M.A., director of the George Washington University Cancer Institute, who was chosen as a Young World Cancer Leader (under 40) by the Union for International Cancer Control.